Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,21/155,381/18800,6.3116576823057295e-12,1.14810110994685e-08,7.37604231692228e-09,B2M/CD160/CD27/CD300A/CD5/CD74/CD83/HAVCR2/HLA-E/IL12B/IL2RA/IL4R/JAM2/LGALS9/LILRB4/TGFBR2/THY1/TNFRSF14/TNFRSF21/UMOD/VSIG4,21
GO:0050863,GO:0050863,regulation of T cell activation,20/155,342/18800,7.1465988792209795e-12,1.14810110994685e-08,7.37604231692228e-09,B2M/CD160/CD27/CD300A/CD5/CD74/CD83/HAVCR2/HLA-E/IL12B/IL2RA/IL4R/LGALS9/LILRB4/TGFBR2/THY1/TNFRSF14/TNFRSF1B/TNFRSF21/VSIG4,20
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,18/155,291/18800,3.4199929888396495e-11,3.66281249104726e-08,2.35319517582967e-08,B2M/CD160/CD27/CD5/CD74/CD83/FSTL3/HAVCR2/HLA-E/IL12B/IL2RA/IL4R/LGALS9/LILRB4/PLAUR/TGFBR2/THY1/TNFRSF14,18
GO:0050870,GO:0050870,positive regulation of T cell activation,16/155,223/18800,4.97248335554998e-11,3.99414725534552e-08,2.56606312111408e-08,B2M/CD160/CD27/CD5/CD74/CD83/HAVCR2/HLA-E/IL12B/IL2RA/IL4R/LGALS9/LILRB4/TGFBR2/THY1/TNFRSF14,16
GO:0050867,GO:0050867,positive regulation of cell activation,21/155,436/18800,7.86514878121735e-11,4.21178717234189e-08,2.70588715087144e-08,ACTA2/B2M/CD160/CD27/CD5/CD74/CD83/HAVCR1/HAVCR2/HLA-E/IL12B/IL2RA/IL4R/LGALS9/LILRA5/LILRB4/NECTIN2/TGFBR2/THY1/TNFRSF14/TNFRSF4,21
GO:0050900,GO:0050900,leukocyte migration,19/155,384/18800,4.2837836980715003e-10,1.52931078021152e-07,9.82514600224352e-08,B4GALT1/BSG/CCL14/CCN3/CD300A/CD74/CSF1/EDN1/JAM2/LGALS9/NBL1/PGF/RARRES2/SCG2/THY1/TNFRSF11A/TNFRSF14/UMOD/XG,19
GO:0002697,GO:0002697,regulation of immune effector process,18/155,353/18800,7.89161450758786e-10,2.34351635787746e-07,1.50560570635665e-07,B2M/CD160/CD300A/CD59/CD74/HAVCR2/HLA-E/IL12B/IL4R/LGALS9/LILRB4/NCR1/NECTIN2/SPON2/TNFRSF14/TNFRSF1B/TNFRSF4/VSIG4,18
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,15/155,233/18800,9.32879318322595e-10,2.49778437480875e-07,1.60471609055317e-07,CD300A/CD74/CSF1/HAVCR2/HLA-E/IL12B/IL2RA/LGALS9/LILRB4/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF21/TNFRSF4/VSIG4,15
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,20/155,486/18800,3.50715119860327e-09,7.0427980006952e-07,4.5246865134612e-07,CCL14/CD74/CSF1/EDA2R/EDN1/IFNGR1/IL10RB/IL12B/IL2RA/IL4R/LILRA5/LILRB4/TFF2/TNFRSF11A/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/YAP1,20
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,14/155,230/18800,7.1400312300539505e-09,1.27449557456463e-06,8.18807090183379e-07,CD300A/CD74/HAVCR2/HLA-E/IL12B/IL2RA/LGALS9/LILRB4/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF21/TNFRSF4/VSIG4,14
GO:0002274,GO:0002274,myeloid leukocyte activation,14/155,232/18800,7.97549861742181e-09,1.34869879251454e-06,8.66479378878902e-07,CD300A/CD74/CSF1/HAVCR1/HAVCR2/IFNGR1/IL4R/LGALS9/LILRB4/LTBR/NECTIN2/PTGDS/TGFBR2/VSIG4,14
GO:0032943,GO:0032943,mononuclear cell proliferation,15/155,300/18800,2.86212584767903e-08,4.18000470390578e-06,2.68546831928162e-06,CD300A/CD74/CSF1/HAVCR2/HLA-E/IL12B/IL2RA/LGALS9/LILRB4/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF21/TNFRSF4/VSIG4,15
GO:0050777,GO:0050777,negative regulation of immune response,12/155,179/18800,3.05210926339428e-08,4.26366394055905e-06,2.73921568215844e-06,AMBP/CD160/CD300A/CD59/HAVCR2/HLA-E/IL12B/IL4R/LGALS9/LILRB4/TNFRSF14/VSIG4,12
GO:0002685,GO:0002685,regulation of leukocyte migration,13/155,218/18800,3.21242436114555e-08,4.3006331134836e-06,2.7629667421958e-06,CCN3/CD300A/CD74/CSF1/EDN1/JAM2/LGALS9/NBL1/PGF/RARRES2/THY1/TNFRSF14/XG,13
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,16/155,373/18800,8.13629068386314e-08,1.00835352015353e-05,6.47822580313883e-06,AREG/CD300A/CD74/EFNA1/EPHA2/EPHB4/EPHB6/GFRA1/IL12B/LILRA5/LILRB4/ROR1/SPINK1/THY1/TNFRSF14/TNFRSF1A,16
GO:0045582,GO:0045582,positive regulation of T cell differentiation,9/155,94/18800,8.15972347463178e-08,1.00835352015353e-05,6.47822580313883e-06,CD27/CD74/CD83/IL12B/IL2RA/IL4R/LGALS9/LILRB4/TGFBR2,9
GO:0050868,GO:0050868,negative regulation of T cell activation,10/155,125/18800,8.54197090660941e-08,1.01649453788652e-05,6.53052824478014e-06,CD300A/CD74/HAVCR2/IL2RA/IL4R/LGALS9/LILRB4/TNFRSF14/TNFRSF21/VSIG4,10
GO:0042269,GO:0042269,regulation of natural killer cell mediated cytotoxicity,7/155,46/18800,9.23853405073855e-08,1.0235658587939e-05,6.57595835698668e-06,CD160/HAVCR2/HLA-E/IL12B/LGALS9/NCR1/NECTIN2,7
GO:0042098,GO:0042098,T cell proliferation,12/155,204/18800,1.28760651342016e-07,1.29283741488093e-05,8.30590912110836e-06,HAVCR2/HLA-E/IL12B/IL2RA/LGALS9/LILRB4/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF21/TNFRSF4/VSIG4,12
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,8/155,72/18800,1.3635249107883e-07,1.32226477376919e-05,8.49496689882021e-06,CD160/HAVCR2/HLA-E/IL12B/LGALS9/NCR1/NECTIN2/ULBP2,8
GO:0031341,GO:0031341,regulation of cell killing,9/155,100/18800,1.39922198282454e-07,1.32226477376919e-05,8.49496689882021e-06,B2M/CD160/CD59/HAVCR2/HLA-E/IL12B/LGALS9/NCR1/NECTIN2,9
GO:0032103,GO:0032103,positive regulation of response to external stimulus,17/155,442/18800,1.50017586696856e-07,1.37716144587714e-05,8.84765375977548e-06,CD160/CD74/CSF1/EDN1/FABP4/HAVCR2/HLA-E/IL12B/LGALS9/LILRA5/NECTIN2/PGF/RARRES2/SCG2/THBD/TNFRSF11A/TNFRSF1A,17
GO:0002507,GO:0002507,tolerance induction,6/155,31/18800,1.76991705809392e-07,1.4965114493831e-05,9.61442479479827e-06,HAVCR2/HLA-E/IL2RA/LGALS9/LILRB4/TGFBR2,6
GO:0044706,GO:0044706,multi-multicellular organism process,12/155,213/18800,2.05763620036724e-07,1.65279627794499e-05,1.06184857603162e-05,ADM/AMBP/B4GALT1/BSG/EDN1/HAVCR2/LGALS9/PGF/SPP1/STC1/TGFBR2/THBD,12
GO:0002443,GO:0002443,leukocyte mediated immunity,17/155,457/18800,2.40540940579001e-07,1.84013819542936e-05,1.18220747988827e-05,B2M/CD160/CD27/CD300A/CD74/HAVCR2/HLA-E/IL12B/IL4R/LGALS9/LILRB4/NCR1/NECTIN2/PTGDS/SPON2/TNFRSF1B/ULBP2,17
GO:0046718,GO:0046718,viral entry into host cell,10/155,146/18800,3.67707747046534e-07,2.56835867665329e-05,1.65005696100287e-05,BSG/CD74/EPHA2/HAVCR1/LGALS9/NECTIN2/NECTIN4/SCARB2/TNFRSF14/TNFRSF4,10
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,8/155,85/18800,5.00838682112838e-07,3.21838937125709e-05,2.06767295920689e-05,B2M/CD160/HAVCR2/HLA-E/IL12B/LGALS9/NCR1/NECTIN2,8
GO:0032102,GO:0032102,negative regulation of response to external stimulus,16/155,429/18800,5.36705015453502e-07,3.33253303615702e-05,2.14100522020867e-05,CCN3/EDN1/HAVCR2/HLA-E/IL12B/IL2RA/LGALS9/NBL1/SEMA3F/SIGLEC10/SPP1/TAFA5/THBD/TNFRSF1A/TNFRSF1B/VSIG4,16
GO:0030595,GO:0030595,leukocyte chemotaxis,12/155,236/18800,6.1784489242644e-07,3.48269410415114e-05,2.2374770711879e-05,BSG/CCL14/CCN3/CD74/CSF1/EDN1/LGALS9/NBL1/PGF/RARRES2/SCG2/TNFRSF11A,12
GO:0043410,GO:0043410,positive regulation of MAPK cascade,17/155,491/18800,6.54929393394993e-07,3.6280830016864e-05,2.33088301351648e-05,ACTA2/CCL14/CD27/CD74/EDA2R/EDN1/EFNA1/GDF15/GPR37/HAVCR2/IGFBP4/IGFBP6/LGALS9/LILRA5/LTBR/TNFRSF11A/TNFRSF19,17
GO:0046631,GO:0046631,alpha-beta T cell activation,10/155,158/18800,7.6303925290641e-07,3.9542663219166e-05,2.5404413836154e-05,CD160/CD300A/CD83/HLA-E/IL12B/IL4R/LGALS9/LILRB4/TGFBR2/TNFRSF14,10
GO:0032613,GO:0032613,interleukin-10 production,7/155,63/18800,8.49367243857209e-07,4.19848762232802e-05,2.69734277765828e-05,CD83/DLL1/IL12B/LGALS9/LILRA5/LILRB4/TNFRSF21,7
GO:0032653,GO:0032653,regulation of interleukin-10 production,7/155,63/18800,8.49367243857209e-07,4.19848762232802e-05,2.69734277765828e-05,CD83/DLL1/IL12B/LGALS9/LILRA5/LILRB4/TNFRSF21,7
GO:0051250,GO:0051250,negative regulation of lymphocyte activation,10/155,161/18800,9.06743377228182e-07,4.34830816572261e-05,2.79359585662917e-05,CD300A/CD74/HAVCR2/IL2RA/IL4R/LGALS9/LILRB4/TNFRSF14/TNFRSF21/VSIG4,10
GO:0034612,GO:0034612,response to tumor necrosis factor,12/155,249/18800,1.08906614615919e-06,5.0015149575974e-05,3.21325235698675e-05,CCL14/EDA2R/EDN1/FABP4/IL18BP/TNFRSF11A/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF21/TNFRSF4,12
GO:0044703,GO:0044703,multi-organism reproductive process,11/155,205/18800,1.08965467485782e-06,5.0015149575974e-05,3.21325235698675e-05,ADM/AMBP/BSG/EDN1/HAVCR2/LGALS9/PGF/SPP1/STC1/TGFBR2/THBD,11
GO:0002700,GO:0002700,regulation of production of molecular mediator of immune response,10/155,167/18800,1.26656499610142e-06,5.73165258094912e-05,3.68233351720518e-05,B2M/CD160/CD74/HLA-E/IL4R/LILRB4/SPON2/TNFRSF14/TNFRSF1B/TNFRSF4,10
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,9/155,131/18800,1.39987619843685e-06,6.24694753552443e-05,4.01338775604482e-05,B2M/CD160/HAVCR2/HLA-E/IL12B/LGALS9/NCR1/NECTIN2/ULBP2,9
GO:0002367,GO:0002367,cytokine production involved in immune response,8/155,100/18800,1.74488129639338e-06,7.47507147374926e-05,4.80240311891569e-05,B2M/CD160/CD74/HLA-E/LILRB4/SPON2/TNFRSF14/TNFRSF1B,8
GO:0042742,GO:0042742,defense response to bacterium,14/155,364/18800,1.99333848042385e-06,8.10708422481243e-05,5.20844338455851e-05,CD160/COLEC12/EPHA2/HAVCR2/HLA-E/IL12B/LCN2/PI3/RARRES2/RNASE6/SPON2/TNFRSF14/TNFRSF1A/WFDC2,14
GO:0033674,GO:0033674,positive regulation of kinase activity,16/155,476/18800,2.09144171566076e-06,8.29605213878769e-05,5.32984691931222e-05,AREG/CD300A/CD74/CSF1/EDN1/EFNA1/EPHA2/EPHB4/EPHB6/IL12B/LILRA5/ROR1/TGFBR2/TNFRSF10A/TNFRSF10B/TNFRSF11A,16
GO:0042060,GO:0042060,wound healing,15/155,429/18800,2.74461200982948e-06,0.0001049814093759,6.74459166826517e-05,ACTA2/ACVRL1/B4GALT1/CD59/CDH3/EDN1/OCLN/PLAUR/REG3A/SDC1/TAFA5/TGFBR2/THBD/TNFRSF12A/YAP1,15
GO:1903131,GO:1903131,mononuclear cell differentiation,15/155,433/18800,3.07382823313215e-06,0.0001148396524773,7.37794022664889e-05,B2M/CD27/CD74/CD79B/CD83/CSF1/DLL1/IL12B/IL2RA/IL4R/LGALS9/LILRB4/LTBR/LY6D/TGFBR2,15
GO:0001906,GO:0001906,cell killing,10/155,185/18800,3.19233783772475e-06,0.0001165566076432,7.48824700930412e-05,B2M/CD160/CD59/HAVCR2/HLA-E/IL12B/LGALS9/NCR1/NECTIN2/ULBP2,10
GO:0045765,GO:0045765,regulation of angiogenesis,13/155,345/18800,5.86525048925544e-06,0.0001983689454945,0.0001274432820989,ACVRL1/ADAM12/ADM/ANGPTL4/CD160/DLL1/EFNA1/EPHA2/HSPB6/HSPG2/PGF/TAFA5/TGFBR2,13
GO:1903034,GO:1903034,regulation of response to wounding,9/155,166/18800,9.80787539289152e-06,0.0003030067657438,0.00019466845795,ACTA2/EDN1/OCLN/REG3A/SIGLEC10/SPP1/TAFA5/THBD/TNFRSF12A,9
GO:0051048,GO:0051048,negative regulation of secretion,9/155,167/18800,1.02944057319492e-05,0.0003150088153976,0.0002023792445148,CCN3/CD300A/CD74/EDN1/IL12B/LGALS9/TFF2/TNFRSF1A/TNFRSF1B,9
GO:0006959,GO:0006959,humoral immune response,12/155,317/18800,1.29573284797129e-05,0.0003854805222714,0.0002476542022292,CD59/CD83/HLA-E/PI3/RARRES2/REG1A/REG3A/RNASE6/SPON2/TNFRSF21/VSIG4/WFDC2,12
GO:0060249,GO:0060249,anatomical structure homeostasis,12/155,319/18800,1.37959011287031e-05,0.000406662663546,0.0002612627920172,B2M/CALB1/CDH3/CSF1/JAM2/OCLN/SPP1/TFF1/TFF2/TFF3/TNFRSF11A/YAP1,12
GO:0001894,GO:0001894,tissue homeostasis,11/155,272/18800,1.6332045857032e-05,0.0004727465165643,0.0003037187475167,B2M/CDH3/CSF1/JAM2/OCLN/SPP1/TFF1/TFF2/TFF3/TNFRSF11A/YAP1,11
GO:0050920,GO:0050920,regulation of chemotaxis,10/155,225/18800,1.78534760239708e-05,0.0005031861268861,0.0003232748521053,CCN3/CD74/CSF1/EDN1/LGALS9/NBL1/PGF/RARRES2/SCG2/SEMA3F,10
GO:0050673,GO:0050673,epithelial cell proliferation,14/155,443/18800,1.86777587075552e-05,0.0005115649770828,0.0003286578931182,ACVRL1/AREG/B2M/B4GALT1/CCN3/CDH3/EPHA2/IGFBP4/IL12B/PGF/REG3A/SCG2/SPINK1/YAP1,14
GO:0002837,GO:0002837,regulation of immune response to tumor cell,4/155,20/18800,1.94295280467913e-05,0.0005116973247077,0.0003287429206191,CD160/HAVCR2/IL12B/NECTIN2,4
GO:0038061,GO:0038061,NIK/NF-kappaB signaling,8/155,141/18800,2.23291710533665e-05,0.0005693938618608,0.0003658103962878,CCN3/CD27/EDN1/HAVCR2/IL12B/LGALS9/TNFRSF10A/TNFRSF10B,8
GO:0032760,GO:0032760,positive regulation of tumor necrosis factor production,7/155,103/18800,2.31007565060094e-05,0.0005844309500299,0.0003754710609886,HAVCR2/HLA-E/IFNGR1/IL12B/LGALS9/LILRA5/SPON2,7
GO:0002834,GO:0002834,regulation of response to tumor cell,4/155,22/18800,2.89603391648165e-05,0.0007103020590576,0.0004563376866388,CD160/HAVCR2/IL12B/NECTIN2,4
GO:0050856,GO:0050856,regulation of T cell receptor signaling pathway,5/155,44/18800,2.99184258496277e-05,0.0007120585352211,0.0004574661449599,CD160/CD300A/LILRB4/NECTIN2/THY1,5
GO:0070227,GO:0070227,lymphocyte apoptotic process,6/155,75/18800,3.59087153923408e-05,0.0008300338313351,0.0005332600597075,CD27/CD74/EFNA1/IL2RA/LGALS9/TNFRSF21,6
GO:0010951,GO:0010951,negative regulation of endopeptidase activity,10/155,251/18800,4.53657091566003e-05,0.0010337590320578,0.0006641444991123,AMBP/CD27/COL6A3/CST3/FABP1/PI3/PLAUR/SPINK1/SPINK4/WFDC2,10
GO:0002064,GO:0002064,epithelial cell development,9/155,203/18800,4.82662207540972e-05,0.0010921082203022,0.0007016312742682,ACTA2/B4GALT1/COL18A1/DLL1/EPHA2/SDC1/STC1/TNFRSF1A/YAP1,9
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,9/155,211/18800,6.50877989977683e-05,0.0014226333209512,0.0009139790464348,ACVRL1/AREG/B4GALT1/CDH3/PGF/REG3A/SCG2/SPINK1/YAP1,9
GO:0002418,GO:0002418,immune response to tumor cell,4/155,27/18800,6.7286819363127e-05,0.0014259057664272,0.0009160814480527,CD160/HAVCR2/IL12B/NECTIN2,4
GO:0048013,GO:0048013,ephrin receptor signaling pathway,5/155,52/18800,6.79002745917759e-05,0.0014259057664272,0.0009160814480527,EFNA1/EFNA4/EPHA2/EPHB4/EPHB6,5
GO:0031348,GO:0031348,negative regulation of defense response,10/155,268/18800,7.84659734693118e-05,0.0016370855373824,0.0010517551194348,CCN3/HAVCR2/HLA-E/IL12B/IL2RA/LGALS9/SIGLEC10/TNFRSF1A/TNFRSF1B/VSIG4,10
GO:0002709,GO:0002709,regulation of T cell mediated immunity,6/155,88/18800,8.85067752327743e-05,0.0018228991591211,0.0011711321608061,B2M/HLA-E/IL12B/LILRB4/NECTIN2/TNFRSF1B,6
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,9/155,221/18800,9.28246562888662e-05,0.0018878883377358,0.001212884836372,CD27/LTBR/SCG2/TNFRSF10A/TNFRSF10B/TNFRSF12A/TNFRSF1A/TNFRSF1B/YAP1,9
GO:0042476,GO:0042476,odontogenesis,7/155,130/18800,0.0001023382594631,0.0020550801728451,0.0013202982026796,ADM/BSG/CSF1/EDN1/KLK4/RELT/SDC1,7
GO:0001666,GO:0001666,response to hypoxia,10/155,286/18800,0.0001339550546984,0.002505012391767,0.0016093597720625,ACVRL1/ADM/ANGPTL4/EDN1/FABP1/HYOU1/NPPC/PGF/STC1/TGFBR2,10
GO:0043434,GO:0043434,response to peptide hormone,12/155,404/18800,0.0001349092584097,0.002505012391767,0.0016093597720625,ADM/AREG/BSG/EDN1/GDF15/NEFL/RARRES2/REG1A/REG3A/RETN/SPINK1/TFF1,12
GO:1903054,GO:1903054,negative regulation of extracellular matrix organization,3/155,13/18800,0.0001479551236054,0.0026518474501946,0.0017036948088625,CST3/TNFRSF1A/TNFRSF1B,3
GO:0061138,GO:0061138,morphogenesis of a branching epithelium,8/155,185/18800,0.0001518290707422,0.0026518474501946,0.0017036948088625,ADM/AREG/CSF1/EDN1/EPHA2/RSPO3/TGFBR2/YAP1,8
GO:0002040,GO:0002040,sprouting angiogenesis,8/155,186/18800,0.0001575596047439,0.0027342511264442,0.0017566355296597,ACVRL1/CLEC14A/DLL1/EPHA2/EPHB4/IL12B/PGF/RSPO3,8
GO:0031099,GO:0031099,regeneration,8/155,188/18800,0.000169556089438,0.0028374151841896,0.0018229138782236,ADM/CCN3/NEFL/PGF/SPP1/TGFBR2/THY1/YAP1,8
GO:0002237,GO:0002237,response to molecule of bacterial origin,11/155,354/18800,0.0001747086892601,0.0029084923243149,0.0018685778000496,ADM/B2M/EDN1/HAVCR2/IL12B/IL18BP/LGALS9/SPON2/THBD/TNFRSF11A/TNFRSF1B,11
GO:0002477,GO:0002477,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,2/155,3/18800,0.0002015199889622,0.0031739398261549,0.0020391160905825,B2M/HLA-E,2
GO:0014028,GO:0014028,notochord formation,2/155,3/18800,0.0002015199889622,0.0031739398261549,0.0020391160905825,EFNA1/EPHA2,2
GO:0090716,GO:0090716,adaptive immune memory response,2/155,3/18800,0.0002015199889622,0.0031739398261549,0.0020391160905825,CD160/TNFRSF14,2
GO:0052548,GO:0052548,regulation of endopeptidase activity,12/155,426/18800,0.0002202107798542,0.003385345625223,0.0021749349750396,AMBP/CD27/COL6A3/CST3/EFNA1/FABP1/LGALS9/PI3/PLAUR/SPINK1/SPINK4/WFDC2,12
GO:0090130,GO:0090130,tissue migration,11/155,366/18800,0.0002329340898744,0.0034489273307215,0.0022157834113207,ACTA2/ACVRL1/CCN3/CLEC14A/EDN1/EFNA1/EPHA2/EPHB4/SCG2/STC1/TGFBR2,11
GO:0001763,GO:0001763,morphogenesis of a branching structure,8/155,199/18800,0.0002497640600592,0.0036811556191307,0.0023649798250906,ADM/AREG/CSF1/EDN1/EPHA2/RSPO3/TGFBR2/YAP1,8
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,11/155,370/18800,0.000255672409962,0.0037510294667028,0.0024098706846214,B2M/CD27/CD74/HAVCR2/HLA-E/IL12B/IL18BP/IL4R/LILRB4/NECTIN2/TNFRSF1B,11
GO:0051346,GO:0051346,negative regulation of hydrolase activity,11/155,371/18800,0.0002616414832672,0.0038146246406143,0.0024507277737627,AMBP/ANGPTL4/CD27/COL6A3/CST3/FABP1/PI3/PLAUR/SPINK1/SPINK4/WFDC2,11
GO:0032370,GO:0032370,positive regulation of lipid transport,5/155,69/18800,0.0002623815890369,0.0038146246406143,0.0024507277737627,EDN1/FABP3/RETN/SPP1/TNFRSF11A,5
GO:0009612,GO:0009612,response to mechanical stimulus,8/155,201/18800,0.0002672373306112,0.0038677186633061,0.0024848383372625,EDN1/LRP11/LTBR/RETN/TGFBR2/TNFRSF10A/TNFRSF10B/TNFRSF1A,8
GO:0002440,GO:0002440,production of molecular mediator of immune response,10/155,312/18800,0.0002701870531794,0.0038928744478276,0.0025009998172522,B2M/CD160/CD74/HLA-E/IL4R/LILRB4/SPON2/TNFRSF14/TNFRSF1B/TNFRSF4,10
GO:0002456,GO:0002456,T cell mediated immunity,6/155,112/18800,0.0003322805766192,0.0046620851208637,0.0029951836853617,B2M/HLA-E/IL12B/LILRB4/NECTIN2/TNFRSF1B,6
GO:0002347,GO:0002347,response to tumor cell,4/155,42/18800,0.0003898429185693,0.0053300650951631,0.0034243313026405,CD160/HAVCR2/IL12B/NECTIN2,4
GO:0044278,GO:0044278,cell wall disruption in another organism,2/155,4/18800,0.000400854443401,0.0054343684668678,0.00349134161008,REG1A/REG3A,2
GO:0001946,GO:0001946,lymphangiogenesis,3/155,18/18800,0.0004095462779805,0.0054558480294495,0.0035051412799156,ACVRL1/CLEC14A/EPHA2,3
GO:0048638,GO:0048638,regulation of developmental growth,10/155,329/18800,0.0004109291077269,0.0054558480294495,0.0035051412799156,AGRN/CSF1/DLL1/EDN1/GDF15/NPPC/SEMA3F/SPP1/TGFBR2/YAP1,10
GO:0140353,GO:0140353,lipid export from cell,4/155,43/18800,0.000427088846103,0.0056470636318073,0.0036279888551359,EDN1/RETN/SPP1/TNFRSF11A,4
GO:0060443,GO:0060443,mammary gland morphogenesis,4/155,44/18800,0.0004668058881284,0.0060969403193359,0.0039170147480523,AREG/CSF1/EPHA2/TGFBR2,4
GO:0003417,GO:0003417,growth plate cartilage development,3/155,19/18800,0.0004834029889611,0.006237645797318,0.0040074118002656,NPPC/STC1/TGFBR2,3
GO:0031645,GO:0031645,negative regulation of nervous system process,3/155,19/18800,0.0004834029889611,0.006237645797318,0.0040074118002656,CCN3/JAM2/TNFRSF21,3
GO:0007520,GO:0007520,myoblast fusion,4/155,45/18800,0.0005090859064156,0.0064651897917526,0.0041535987621429,ADAM12/GDF15/IL4R/JAM2,4
GO:0043542,GO:0043542,endothelial cell migration,9/155,279/18800,0.0005228177621361,0.0066134388572576,0.004248842236009,ACVRL1/CCN3/CLEC14A/EDN1/EFNA1/EPHA2/EPHB4/SCG2/STC1,9
GO:0048659,GO:0048659,smooth muscle cell proliferation,7/155,173/18800,0.000587472740344,0.0073732418543957,0.0047369820880534,CCN3/EDN1/IL12B/NPPC/OGN/TAFA5/TGFBR2,7
GO:0048771,GO:0048771,tissue remodeling,7/155,174/18800,0.0006079331891877,0.007541657671275,0.004845181808564,ACVRL1/CST3/EPHA2/IL12B/RSPO3/SPP1/TNFRSF11A,7
GO:0061564,GO:0061564,axon development,12/155,479/18800,0.0006303174998896,0.0077892697197904,0.0050042616084357,BSG/EDN1/EFNA1/EFNA4/EPHA2/EPHB4/EPHB6/NEFL/SEMA3F/SPP1/THY1/TNFRSF21,12
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,2/155,5/18800,0.0006644702647888,0.0079960410515606,0.0051371030524384,TNFRSF1A/TNFRSF1B,2
GO:0031349,GO:0031349,positive regulation of defense response,9/155,289/18800,0.0006726728045844,0.0080187150412024,0.0051516700888816,CD160/FABP4/HAVCR2/HLA-E/IL12B/LILRA5/NECTIN2/TNFRSF11A/TNFRSF1A,9
GO:0042542,GO:0042542,response to hydrogen peroxide,6/155,128/18800,0.000676337309731,0.0080187150412024,0.0051516700888816,AREG/EDN1/FABP1/GPR37/IL18BP/SDC1,6
GO:0001503,GO:0001503,ossification,11/155,420/18800,0.0007390959276744,0.008653231503042,0.0055593188780662,AREG/CSF1/EPHA2/FSTL3/NPPC/PHOSPHO1/SMOC1/SPP1/STC1/TNFRSF11A/YAP1,11
GO:0006692,GO:0006692,prostanoid metabolic process,4/155,50/18800,0.0007621738298664,0.008653231503042,0.0055593188780662,CD74/EDN1/PTGDS/TNFRSF1A,4
GO:0006693,GO:0006693,prostaglandin metabolic process,4/155,50/18800,0.0007621738298664,0.008653231503042,0.0055593188780662,CD74/EDN1/PTGDS/TNFRSF1A,4
GO:0030857,GO:0030857,negative regulation of epithelial cell differentiation,4/155,50/18800,0.0007621738298664,0.008653231503042,0.0055593188780662,ACVRL1/DLL1/REG3A/YAP1,4
GO:0043303,GO:0043303,mast cell degranulation,4/155,50/18800,0.0007621738298664,0.008653231503042,0.0055593188780662,CD300A/IL4R/LGALS9/PTGDS,4
GO:0051591,GO:0051591,response to cAMP,5/155,89/18800,0.0008493039880632,0.0094097024608526,0.0060453180420764,AREG/BSG/SDC1/STC1/THBD,5
GO:0046697,GO:0046697,decidualization,3/155,23/18800,0.0008623924731611,0.0094568840145627,0.0060756301055113,BSG/SPP1/STC1,3
GO:0002279,GO:0002279,mast cell activation involved in immune response,4/155,52/18800,0.0008846053329089,0.0096674725667905,0.0062109239449854,CD300A/IL4R/LGALS9/PTGDS,4
GO:2001188,GO:2001188,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/155,6/18800,0.0009913075980099,0.0104772082644929,0.0067311433507529,HAVCR2/LGALS9,2
GO:0006898,GO:0006898,receptor-mediated endocytosis,8/155,246/18800,0.0010123779737327,0.0106648210806665,0.006851676295047,ADM/ASGR1/B2M/DLL1/HSPG2/LILRB4/SCARB2/TGFBR2,8
GO:0030101,GO:0030101,natural killer cell activation,5/155,93/18800,0.0010357725360083,0.010840186183045,0.0069643406244209,HAVCR2/HLA-E/IL12B/NCR1/ULBP2,5
GO:0051384,GO:0051384,response to glucocorticoid,6/155,139/18800,0.0010399613817589,0.0108486880506217,0.0069698026986646,ADM/AREG/EDN1/NEFL/SDC1/STC1,6
GO:0051960,GO:0051960,regulation of nervous system development,11/155,440/18800,0.0010781933911803,0.0112111176888757,0.0072026477264682,AGRN/B2M/DLL1/JAM2/NEFL/SEMA3F/SPP1/THY1/TNFRSF1B/TNFRSF21/YAP1,11
GO:1905954,GO:1905954,positive regulation of lipid localization,5/155,94/18800,0.0010867883075127,0.0112640349420599,0.0072366447233703,EDN1/FABP3/RETN/SPP1/TNFRSF11A,5
GO:0019883,GO:0019883,antigen processing and presentation of endogenous antigen,3/155,26/18800,0.0012433569944109,0.0125532125525021,0.008064884372846,B2M/CD74/HLA-E,3
GO:0070228,GO:0070228,regulation of lymphocyte apoptotic process,4/155,57/18800,0.0012502421465299,0.0125532125525021,0.008064884372846,CD27/CD74/EFNA1/LGALS9,4
GO:0043305,GO:0043305,negative regulation of mast cell degranulation,2/155,7/18800,0.0013803194993767,0.0135625888424998,0.0087133640375913,CD300A/LGALS9,2
GO:0090027,GO:0090027,negative regulation of monocyte chemotaxis,2/155,7/18800,0.0013803194993767,0.0135625888424998,0.0087133640375913,CCN3/NBL1,2
GO:0031102,GO:0031102,neuron projection regeneration,4/155,59/18800,0.0014222911406802,0.0137231874925092,0.0088165415738072,ADM/NEFL/SPP1/THY1,4
GO:0140253,GO:0140253,cell-cell fusion,4/155,59/18800,0.0014222911406802,0.0137231874925092,0.0088165415738072,ADAM12/GDF15/IL4R/JAM2,4
GO:0061448,GO:0061448,connective tissue development,8/155,260/18800,0.0014405166727435,0.0138574253578593,0.0089027834706905,ACTA2/ACVRL1/CCN3/CSF1/EDN1/NPPC/STC1/TGFBR2,8
GO:0003416,GO:0003416,endochondral bone growth,3/155,28/18800,0.0015478497256213,0.0146703279304465,0.0094250374536359,NPPC/STC1/TGFBR2,3
GO:0022600,GO:0022600,digestive system process,5/155,104/18800,0.0017049420608905,0.0158008151314463,0.0101513255271402,FABP1/SPINK1/TFF1/TFF2/TFF3,5
GO:0045136,GO:0045136,development of secondary sexual characteristics,2/155,8/18800,0.0018304717980193,0.0165205221545957,0.0106137054876283,AREG/B4GALT1,2
GO:0003170,GO:0003170,heart valve development,4/155,65/18800,0.0020365752661343,0.0180262157853711,0.0115810471129172,EFNA1/TGFBR2/TNFRSF1A/TNFRSF1B,4
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,8/155,279/18800,0.0022391917861535,0.0196571672374629,0.0126288613536012,BSG/CDH3/DSC2/NECTIN2/NECTIN4/REG3A/TGFBR2/UMOD,8
GO:0001516,GO:0001516,prostaglandin biosynthetic process,3/155,32/18800,0.002287723198015,0.0198125461865827,0.0127286854626398,CD74/EDN1/PTGDS,3
GO:0046457,GO:0046457,prostanoid biosynthetic process,3/155,32/18800,0.002287723198015,0.0198125461865827,0.0127286854626398,CD74/EDN1/PTGDS,3
GO:0007568,GO:0007568,aging,6/155,163/18800,0.0023399899298037,0.019843818274859,0.0127487763975293,ADM/EDN1/GFRA1/RETN/TGFBR2/TNFRSF1B,6
GO:0051146,GO:0051146,striated muscle cell differentiation,8/155,281/18800,0.00234023004874,0.019843818274859,0.0127487763975293,ADAM12/CCN3/DLL1/EDN1/GDF15/IL4R/JAM2/SDC1,8
GO:1904238,GO:1904238,pericyte cell differentiation,2/155,9/18800,0.002340742958659,0.019843818274859,0.0127487763975293,ACTA2/EPHA2,2
GO:0071260,GO:0071260,cellular response to mechanical stimulus,4/155,70/18800,0.0026718757105941,0.0221827820623747,0.0142514572785941,LTBR/TNFRSF10A/TNFRSF10B/TNFRSF1A,4
GO:0033006,GO:0033006,regulation of mast cell activation involved in immune response,3/155,34/18800,0.0027270173556489,0.022524181911825,0.0144707915963401,CD300A/IL4R/LGALS9,3
GO:0045446,GO:0045446,endothelial cell differentiation,5/155,117/18800,0.002852404540188,0.0230301188120889,0.0147958336987916,ACVRL1/COL18A1/DLL1/STC1/TNFRSF1A,5
GO:0008037,GO:0008037,cell recognition,7/155,228/18800,0.0028746491707636,0.0230301188120889,0.0147958336987916,B4GALT1/BSG/CD5/COLEC12/HAVCR2/SPON2/TNFRSF21,7
GO:0048660,GO:0048660,regulation of smooth muscle cell proliferation,6/155,170/18800,0.0028847986086252,0.0230301188120889,0.0147958336987916,EDN1/IL12B/NPPC/OGN/TAFA5/TGFBR2,6
GO:1904019,GO:1904019,epithelial cell apoptotic process,5/155,118/18800,0.0029591690458528,0.0233034562360908,0.0149714409156794,ANGPTL4/CD160/SCG2/TGFBR2/YAP1,5
GO:0021700,GO:0021700,developmental maturation,8/155,296/18800,0.0032170849152988,0.0250885772642118,0.0161183022966302,ACVRL1/AGRN/CDH3/EDN1/NEFL/NPPC/PHOSPHO1/SPINK1,8
GO:0060560,GO:0060560,developmental growth involved in morphogenesis,7/155,234/18800,0.0033182632373277,0.0258149631514144,0.0165849731321518,AREG/CSF1/EDN1/SEMA3F/SPP1/TGFBR2/YAP1,7
GO:0001886,GO:0001886,endothelial cell morphogenesis,2/155,11/18800,0.0035376180890036,0.0268074691508693,0.0172226143806754,COL18A1/STC1,2
GO:0046598,GO:0046598,positive regulation of viral entry into host cell,2/155,11/18800,0.0035376180890036,0.0268074691508693,0.0172226143806754,CD74/LGALS9,2
GO:0075294,GO:0075294,positive regulation by symbiont of entry into host,2/155,11/18800,0.0035376180890036,0.0268074691508693,0.0172226143806754,CD74/LGALS9,2
GO:0043299,GO:0043299,leukocyte degranulation,4/155,76/18800,0.0035990760843973,0.0272090151980439,0.0174805899727633,CD300A/IL4R/LGALS9/PTGDS,4
GO:0046683,GO:0046683,response to organophosphorus,5/155,124/18800,0.0036613069883465,0.0276145055247826,0.0177410995901842,AREG/BSG/SDC1/STC1/THBD,5
GO:0010876,GO:0010876,lipid localization,10/155,446/18800,0.003951735933081,0.0293910360022901,0.0188824419219588,EDN1/FABP1/FABP3/FABP4/GM2A/NPC2/RETN/SCARB2/SPP1/TNFRSF11A,10
GO:0032418,GO:0032418,lysosome localization,4/155,79/18800,0.004135570436588,0.0304063794342272,0.0195347552117285,CD300A/IL4R/LGALS9/PTGDS,4
GO:1990849,GO:1990849,vacuolar localization,4/155,79/18800,0.004135570436588,0.0304063794342272,0.0195347552117285,CD300A/IL4R/LGALS9/PTGDS,4
GO:0001570,GO:0001570,vasculogenesis,4/155,80/18800,0.00432576118111,0.0309547231066964,0.0198870417914825,ADM/EPHA2/TGFBR2/YAP1,4
GO:1903115,GO:1903115,regulation of actin filament-based movement,3/155,40/18800,0.0043431142146033,0.0310098354922677,0.0199224490639464,ACTA2/DSC2/STC1,3
GO:0071695,GO:0071695,anatomical structure maturation,7/155,246/18800,0.004360568277055,0.0310654232243413,0.0199581617255338,ACVRL1/AGRN/CDH3/EDN1/NPPC/PHOSPHO1/SPINK1,7
GO:0031345,GO:0031345,negative regulation of cell projection organization,6/155,188/18800,0.0047193187597062,0.0334298618159277,0.0214772090425522,B2M/EFNA1/SEMA3F/SPP1/THY1/YAP1,6
GO:0003158,GO:0003158,endothelium development,5/155,133/18800,0.0049278950191228,0.0341697074133303,0.0219525271471295,ACVRL1/COL18A1/DLL1/STC1/TNFRSF1A,5
GO:0010713,GO:0010713,negative regulation of collagen metabolic process,2/155,13/18800,0.004963020191395,0.0341697074133303,0.0219525271471295,CST3/NPPC,2
GO:0045683,GO:0045683,negative regulation of epidermis development,2/155,13/18800,0.004963020191395,0.0341697074133303,0.0219525271471295,DLL1/REG3A,2
GO:0060670,GO:0060670,branching involved in labyrinthine layer morphogenesis,2/155,13/18800,0.004963020191395,0.0341697074133303,0.0219525271471295,ADM/RSPO3,2
GO:0035050,GO:0035050,embryonic heart tube development,4/155,84/18800,0.0051454878025667,0.0351007480034967,0.0225506795861736,DLL1/EDN1/TGFBR2/YAP1,4
GO:0003007,GO:0003007,heart morphogenesis,7/155,254/18800,0.0051818896261701,0.0352741766289927,0.022662099814718,ACVRL1/DLL1/EDN1/EFNA1/EPHB4/TGFBR2/YAP1,7
GO:0014002,GO:0014002,astrocyte development,3/155,43/18800,0.0053282240912965,0.0360412294849172,0.0231548973806813,DLL1/IFNGR1/ROR1,3
GO:0010977,GO:0010977,negative regulation of neuron projection development,5/155,136/18800,0.0054116184921255,0.0364518453148834,0.0234186999074439,B2M/EFNA1/SEMA3F/SPP1/THY1,5
GO:0007586,GO:0007586,digestion,5/155,137/18800,0.0055800629871069,0.0375078292417879,0.0240971229194378,FABP1/SPINK1/TFF1/TFF2/TFF3,5
GO:0034103,GO:0034103,regulation of tissue remodeling,4/155,86/18800,0.0055918373573125,0.0375085040272343,0.0240975564392703,CST3/IL12B/SPP1/TNFRSF11A,4
GO:0040013,GO:0040013,negative regulation of locomotion,9/155,396/18800,0.005651421058395,0.0376090495182323,0.0241621524744061,ACVRL1/CCN3/CD300A/CD74/NBL1/SEMA3F/STC1/TAFA5/THY1,9
GO:0032306,GO:0032306,regulation of prostaglandin secretion,2/155,14/18800,0.0057589954444351,0.0376090495182323,0.0241621524744061,EDN1/TNFRSF11A,2
GO:0032308,GO:0032308,positive regulation of prostaglandin secretion,2/155,14/18800,0.0057589954444351,0.0376090495182323,0.0241621524744061,EDN1/TNFRSF11A,2
GO:0043301,GO:0043301,negative regulation of leukocyte degranulation,2/155,14/18800,0.0057589954444351,0.0376090495182323,0.0241621524744061,CD300A/LGALS9,2
GO:0070278,GO:0070278,extracellular matrix constituent secretion,2/155,14/18800,0.0057589954444351,0.0376090495182323,0.0241621524744061,TNFRSF1A/TNFRSF1B,2
GO:0034341,GO:0034341,response to interferon-gamma,5/155,140/18800,0.0061075914840337,0.0393260349462935,0.0252652397430444,CCL14/CD74/EDN1/IL12B/LGALS9,5
GO:0070301,GO:0070301,cellular response to hydrogen peroxide,4/155,90/18800,0.0065605762575331,0.0415565910331183,0.0266982734666552,EDN1/FABP1/GPR37/IL18BP,4
GO:0032924,GO:0032924,activin receptor signaling pathway,3/155,47/18800,0.0068351380651944,0.042396329350328,0.0272377682297224,ACVRL1/FSTL3/TGFBR2,3
GO:0034349,GO:0034349,glial cell apoptotic process,2/155,16/18800,0.0075127515884122,0.0449748040313517,0.0288943242765347,DLL1/TNFRSF21,2
GO:0045780,GO:0045780,positive regulation of bone resorption,2/155,16/18800,0.0075127515884122,0.0449748040313517,0.0288943242765347,SPP1/TNFRSF11A,2
GO:0060046,GO:0060046,regulation of acrosome reaction,2/155,16/18800,0.0075127515884122,0.0449748040313517,0.0288943242765347,B4GALT1/SPINK1,2
GO:1901741,GO:1901741,positive regulation of myoblast fusion,2/155,16/18800,0.0075127515884122,0.0449748040313517,0.0288943242765347,GDF15/IL4R,2
GO:1904035,GO:1904035,regulation of epithelial cell apoptotic process,4/155,94/18800,0.0076346156561088,0.0449748040313517,0.0288943242765347,ANGPTL4/CD160/SCG2/YAP1,4
GO:0010862,GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,3/155,49/18800,0.0076739610169974,0.0449748040313517,0.0288943242765347,ACVRL1/GDF15/TGFBR2,3
GO:1903532,GO:1903532,positive regulation of secretion by cell,7/155,274/18800,0.0077415743884066,0.0449748040313517,0.0288943242765347,EDN1/IL4R/RETN/SDC1/SPINK1/SPP1/TNFRSF11A,7
GO:0038084,GO:0038084,vascular endothelial growth factor signaling pathway,3/155,50/18800,0.0081151389225589,0.0449748040313517,0.0288943242765347,DLL1/IL12B/PGF,3
GO:0001815,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,HLA-E,1
GO:0010711,GO:0010711,negative regulation of collagen catabolic process,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CST3,1
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,DLL1,1
GO:0031583,GO:0031583,phospholipase D-activating G protein-coupled receptor signaling pathway,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,EDN1,1
GO:0036325,GO:0036325,vascular endothelial growth factor receptor-3 signaling pathway,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CLEC14A,1
GO:0042313,GO:0042313,protein kinase C deactivation,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,EDN1,1
GO:0043179,GO:0043179,rhythmic excitation,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,EDN1,1
GO:0044722,GO:0044722,renal phosphate excretion,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,STC1,1
GO:0045887,GO:0045887,positive regulation of synaptic assembly at neuromuscular junction,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,AGRN,1
GO:0046814,GO:0046814,coreceptor-mediated virion attachment to host cell,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,NECTIN2,1
GO:0048673,GO:0048673,collateral sprouting of intact axon in response to injury,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,SPP1,1
GO:0048683,GO:0048683,regulation of collateral sprouting of intact axon in response to injury,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,SPP1,1
GO:0048685,GO:0048685,negative regulation of collateral sprouting of intact axon in response to injury,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,SPP1,1
GO:0051796,GO:0051796,negative regulation of timing of catagen,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CDH3,1
GO:0060101,GO:0060101,"negative regulation of phagocytosis, engulfment",1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CD300A,1
GO:0060311,GO:0060311,negative regulation of elastin catabolic process,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CST3,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,DLL1,1
GO:0060901,GO:0060901,regulation of hair cycle by canonical Wnt signaling pathway,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CDH3,1
GO:0061872,GO:0061872,hepatic stellate cell contraction,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,ACTA2,1
GO:0071283,GO:0071283,cellular response to iron(III) ion,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,B2M,1
GO:0072027,GO:0072027,connecting tubule development,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CALB1,1
GO:0072286,GO:0072286,metanephric connecting tubule development,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CALB1,1
GO:0090143,GO:0090143,nucleoid organization,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CHCHD10,1
GO:0090144,GO:0090144,mitochondrial nucleoid organization,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CHCHD10,1
GO:1902228,GO:1902228,positive regulation of macrophage colony-stimulating factor signaling pathway,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CSF1,1
GO:1902910,GO:1902910,positive regulation of melanosome transport,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CDH3,1
GO:1903402,GO:1903402,regulation of renal phosphate excretion,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,STC1,1
GO:1903403,GO:1903403,negative regulation of renal phosphate excretion,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,STC1,1
GO:1905154,GO:1905154,negative regulation of membrane invagination,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,CD300A,1
GO:1905317,GO:1905317,inferior endocardial cushion morphogenesis,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,TGFBR2,1
GO:2000184,GO:2000184,positive regulation of progesterone biosynthetic process,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,ADM,1
GO:2000196,GO:2000196,positive regulation of female gonad development,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,RETN,1
GO:2000872,GO:2000872,positive regulation of progesterone secretion,1/155,1/18800,0.0082446808510632,0.0449748040313517,0.0288943242765347,RETN,1
GO:0019885,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,2/155,17/18800,0.008468670435644,0.0455776182742451,0.0292816057908807,B2M/HLA-E,2
GO:0048532,GO:0048532,anatomical structure arrangement,2/155,17/18800,0.008468670435644,0.0455776182742451,0.0292816057908807,DLL1/SEMA3F,2
GO:0060284,GO:0060284,regulation of cell development,10/155,500/18800,0.0086128296923087,0.0460449613999799,0.0295818530985505,B2M/DLL1/NEFL/NPPC/SEMA3F/SPP1/THY1/TNFRSF1A/TNFRSF1B/YAP1,10
GO:0016064,GO:0016064,immunoglobulin mediated immune response,6/155,216/18800,0.0091042297974983,0.0481116617423721,0.0309096167467007,B2M/CD27/CD74/HLA-E/IL4R/NECTIN2,6
GO:0034138,GO:0034138,toll-like receptor 3 signaling pathway,2/155,18/18800,0.0094760609553519,0.0493461650721976,0.0317027305867871,COLEC12/HAVCR2,2
